It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19)

Clin Infect Dis. 2022 Feb 11;74(3):560-562. doi: 10.1093/cid/ciab480.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • COVID-19 Drug Treatment*
  • Humans
  • SARS-CoV-2

Substances

  • Antibodies, Monoclonal, Humanized
  • tocilizumab